Trial Profile
Stabilisation Of Microcirculation In Early Systemic Sclerosis Patients With Diffuse Skin Involvement Following Rituximab Treatment
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Methylprednisolone
- Indications Systemic scleroderma
- Focus Therapeutic Use
- 16 Dec 2015 New trial record